Finance

Lists
Why is 688068 down 4,05%?
Dive Deeper
688068:SHA
Beijing Hotgen Biotech Co Ltd
72,73 CNY
-4,05%
(-3,07) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688068...
Open
77,88 CNY
High
79,49 CNY
Low
71,68 CNY
Mkt. cap
7,15 მლრდ.
Avg. vol.
2,28 მლნ.
Volume
3,10 მლნ.
52-wk high
214,78 CNY
52-wk low
71,68 CNY
EPS
-3,00 CNY
No. of employees
1 ათ.
Open
77,88 CNY
High
79,49 CNY
Low
71,68 CNY
Mkt. cap
7,15 მლრდ.
Avg. vol.
2,28 მლნ.
Volume
3,10 მლნ.
52-wk high
214,78 CNY
52-wk low
71,68 CNY
EPS
-3,00 CNY
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd
CEO-
Employees1,04 ათ.
Founded23 ივნ. 2005
Headquarters-
SectorHealth care
Websitehotgen.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
105,80 მლნ.
95,17 მლნ.
116,03 მლნ.
151,72 მლნ.
Cost of goods sold
49,91 მლნ.
40,31 მლნ.
55,11 მლნ.
36,50 მლნ.
Cost of revenue
49,91 მლნ.
40,31 მლნ.
55,11 მლნ.
36,50 მლნ.
Research and development expenses
19,65 მლნ.
94,81 მლნ.
49,10 მლნ.
46,03 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83,78 მლნ.
99,31 მლნ.
97,60 მლნ.
127,34 მლნ.
Operating expense
98,59 მლნ.
204,82 მლნ.
143,51 მლნ.
186,68 მლნ.
Total operating expenses
148,50 მლნ.
245,13 მლნ.
198,62 მლნ.
223,17 მლნ.
Operating income
-42,70 მლნ.
-149,96 მლნ.
-82,59 მლნ.
-71,46 მლნ.
Other non operating income
-273,76 ათ.
2,19 მლნ.
-2,39 მლნ.
2,09 მლნ.
EBT including unusual items
-20,92 მლნ.
-155,14 მლნ.
-82,67 მლნ.
-76,94 მლნ.
EBT excluding unusual items
-28,82 მლნ.
-122,01 მლნ.
-69,59 მლნ.
-76,99 მლნ.
Income tax expense
4,59 მლნ.
-6,98 მლნ.
-5,78 ათ.
-796,34 ათ.
Effective tax rate
-21,96%
4,50%
0,01%
1,03%
Other operating expenses
-5,37 მლნ.
6,99 მლნ.
-2,96 მლნ.
3,17 მლნ.
Net income
-24,96 მლნ.
-107,09 მლნ.
-68,06 მლნ.
-58,07 მლნ.
Net profit margin
-23,59%
-112,52%
-58,66%
-38,27%
Earnings per share
-
-
-
-
Interest and investment income
14,98 მლნ.
35,99 მლნ.
15,44 მლნ.
3,94 მლნ.
Interest expense
-289,66 ათ.
-7,96 მლნ.
-46,88 ათ.
-7,63 მლნ.
Net interest expenses
14,69 მლნ.
28,03 მლნ.
15,39 მლნ.
-3,69 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,62 მლნ.
-129,90 მლნ.
-62,53 მლნ.
-53,46 მლნ.
Gain or loss from assets sale
601,43 ათ.
-579,43 ათ.
-
6,83 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები